rs138398671

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. BP4PM3_Supporting

This summary comes from the ClinGen Evidence Repository: The variant NM_206933.4:c.13396C>T in USH2A is a missense variant predicted to cause substitution of proline by serine at amino acid 4466 (p.Pro4466Ser). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00044 (57/128120 alleles) in the European (non-Finnish) population, which does not meet either PM2_supporting nor BS1 criteria. The REVEL computational prediction analysis tool produced a score of 0.049, which is below the threshold necessary to apply BP4. This variant has been reported in two probands, one with retinitis pigmentosa, however the second variant was not specified and no PM3 points were awarded and the other homozygous with inherited retinal disease (PM3_Supporting; PMID 28041643, 32581362). In summary, the variant meets criteria to be classified as uncertain significance for AR Usher syndrome. ACMG/AMP criteria met, as specified by the ClinGen Hearing Loss VCEP: BP4, PM3_Supporting (ClinGen Hearing Loss VCEP specifications version 2; 11/22/2022) LINK:https://erepo.genome.network/evrepo/ui/classification/CA143316/MONDO:0019501/005

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 0 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

1
18

Clinical Significance

Uncertain significance reviewed by expert panel P:1U:8

Conservation

PhyloP100: 0.646
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM3
For more information check the summary or visit ClinGen Evidence Repository.
BP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
USH2ANM_206933.4 linkuse as main transcriptc.13396C>T p.Pro4466Ser missense_variant 63/72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkuse as main transcriptc.13396C>T p.Pro4466Ser missense_variant 63/721 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkuse as main transcriptc.13396C>T p.Pro4466Ser missense_variant 63/73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000216
AC:
54
AN:
250296
Hom.:
0
AF XY:
0.000200
AC XY:
27
AN XY:
135252
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000435
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000342
AC:
500
AN:
1461870
Hom.:
0
Cov.:
30
AF XY:
0.000334
AC XY:
243
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000749
Gnomad4 NFE exome
AF:
0.000433
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.000250
AC:
38
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.000283
AC XY:
21
AN XY:
74336
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000470
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000369
Hom.:
0
Bravo
AF:
0.000215
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000272
AC:
33
EpiCase
AF:
0.000218
EpiControl
AF:
0.000474

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 14, 2021The p.Pro4466Ser in exon 63 of USH2A has been identified in one individual with retinitis pigmentosa. This individual also carried a large deletion of the USH2A gene (chr1:215836170-215851932) (Carss 2017, PMID: 28041643). It has also been identified in 0.04% (57/128120) of European American chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant was classified as Uncertain Significance on Mar 25, 2019 by the ClinGen-approved Hearing Loss Variant Curation expert panel (Variation ID 48417). Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. This variant has a lack of conservation of the amino acid position. Of note, chicken has a serine (Ser) at this position despite high nearby amino acid conservation. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PM3_Supporting, BP4. -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 19, 2022This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 4466 of the USH2A protein (p.Pro4466Ser). This variant is present in population databases (rs138398671, gnomAD 0.05%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 28041643). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 48417). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt USH2A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Retinitis pigmentosa Pathogenic:1
Likely pathogenic, no assertion criteria providedresearchNIHR Bioresource Rare Diseases, University of CambridgeJan 01, 2015- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 11, 2024Variant summary: USH2A c.13396C>T (p.Pro4466Ser) results in a non-conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00022 in 250296 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in USH2A causing Usher Syndrome (0.00022 vs 0.011), allowing no conclusion about variant significance. c.13396C>T has been reported in the literature as homozygous or compound heterozygous genotype in two individuals affected with clinical features of Usher Syndrome (Carss_2017, Lin_2024)). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28041643, 38219857). ClinVar contains an entry for this variant (Variation ID: 48417). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Usher syndrome Uncertain:1
Uncertain significance, reviewed by expert panelcurationClinGen Hearing Loss Variant Curation Expert PanelNov 22, 2022The variant NM_206933.4:c.13396C>T in USH2A is a missense variant predicted to cause substitution of proline by serine at amino acid 4466 (p.Pro4466Ser). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00044 (57/128120 alleles) in the European (non-Finnish) population, which does not meet either PM2_supporting nor BS1 criteria. The REVEL computational prediction analysis tool produced a score of 0.049, which is below the threshold necessary to apply BP4. This variant has been reported in two probands, one with retinitis pigmentosa, however the second variant was not specified and no PM3 points were awarded and the other homozygous with inherited retinal disease (PM3_Supporting; PMID 28041643, 32581362). In summary, the variant meets criteria to be classified as uncertain significance for AR Usher syndrome. ACMG/AMP criteria met, as specified by the ClinGen Hearing Loss VCEP: BP4, PM3_Supporting (ClinGen Hearing Loss VCEP specifications version 2; 11/22/2022) -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCounsylMar 30, 2018- -
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Nov 06, 2019- -
USH2A-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 11, 2024The USH2A c.13396C>T variant is predicted to result in the amino acid substitution p.Pro4466Ser. This variant was reported, along with a large deletion in the same gene, in an individual with retinitis pigmentosa (Table S2, Carss et al. 2017. PubMed ID: 28041643). This variant was also described in the homozygous state in an individual with retinal disease (Turro et al. 2020. PubMed ID: 32581362). This variant is reported in 0.044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
17
DANN
Benign
0.79
DEOGEN2
Benign
0.086
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.69
T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.084
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
2.0
M
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.049
Sift
Benign
0.61
T
Sift4G
Benign
0.93
T
Polyphen
0.045
B
Vest4
0.072
MVP
0.82
MPC
0.037
ClinPred
0.028
T
GERP RS
1.2
Varity_R
0.060
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138398671; hg19: chr1-215847857; API